All Updates

All Updates

icon
Filter
Funding
Atropos Health raises USD 33 million in Series B funding to amplify stake in value-based care
Telehealth
May 23, 2024
This week:
Robinhood launches joint investment accounts
Retail Trading Infrastructure
Jul 25, 2024
Partnerships
eToro partners with London Stock Exchange to expand UK stock offerings
Retail Trading Infrastructure
Jul 25, 2024
Funding
StorMagic secures funding from Palatine Growth Credit Fund
Edge Computing
Jul 25, 2024
Funding
Archera raises USD 17 million in Series B funding for product development and recruitment
Cloud Optimization Tools
Jul 25, 2024
Funding
Alto Neuroscience receives grant of USD 11.7 million to support Phase IIb clinical trials of ALTO-100
Precision Medicine
Jul 25, 2024
Partnerships
Quest Diagnostics and BD partner to develop flow cytometry-based companion diagnostics for cancer and other diseases
Precision Medicine
Jul 25, 2024
Product updates
USPACE Technology Group Limited unveils commercial optical satellites and related aerospace products
Next-gen Satellites
Jul 25, 2024
Industry news
Sweden issues study on Gripen fighter jet’s satellite launch capability
Next-gen Satellites
Jul 25, 2024
Product updates
Regulation/policy
Terran Orbital receives certification for new manufacturing facility to begin production
Next-gen Satellites
Jul 25, 2024
Partnerships
Crisalion Mobility partners with Air Chateau for pre-order of eVTOL aircraft
Passenger eVTOL Aircraft
Jul 25, 2024
May 23, 2024

Atropos Health raises USD 33 million in Series B funding to amplify stake in value-based care

Funding

  • Atropos Health, a health tech company focusing on personalized real-world evidence for care, has secured USD 33 million in Series B funding. The round was led by Valtruis, and contributions from other venture capital firms brought the total funds raised by the company to USD 47 million.

  • The company intends to use the raised funds to amplify its stake in value-based care. Specifically, it plans to fuel its work in GenAI capabilities, scaling the automation of generating personalized real-world data. Additionally, the company plans to secure partnerships with pharmaceutical and vertically integrated healthcare companies to drive evidence adoption in oncology and other specialty areas.

  • Post funding Mike Spadafore, a value-based care veteran, joined Atropos’ board of directors.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.